hCD44v9/CT26
CBPG0279
询 价
留 言
产品描述
产品数据库
| I. Background | |||
|
CD44v9是CD44基因的可变剪接变异体，在多种上皮性肿瘤和肿瘤干细胞表面高表达。它顺利获得与xCT（胱氨酸/谷氨酸转运蛋白）相互作用，增强细胞内谷胱甘肽合成，清除活性氧，从而赋予肿瘤细胞抗氧化应激和耐药能力，并促进肿瘤侵袭、转移和复发。其高表达通常提示预后不良，是重要的肿瘤标志物和潜在治疗靶点。
|
|||
| II. Introduction | |||
| Host Cell: | CT26.WT | ||
| Expressed gene: | hCD44v9 | ||
| Stability: | 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) | ||
| Freeze Medium: | 90% FBS+10% DMSO | ||
| Culture Medium: | RPMI-1640+10%FBS+10 μg/ml Blasticidin | ||
| Mycoplasma Testing: | Negative | ||
| Storage: | Liquid nitrogen | ||
| III. Introduction | |||
| Organism: | Mus musculus, mouse | ||
| Tissue: | Colon | ||
| Morphology: | Fibroblast | ||
| Growth Properties: | Adherent | ||
IV. Representative Data Figure 1. Recombinant hCD44v9/CT26 stably expressing hCD44v9. |
|||
|
|
|||
